337 related articles for article (PubMed ID: 21965171)
1. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward.
Lai DY
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(1):1-15. PubMed ID: 21965171
[TBL] [Abstract][Full Text] [Related]
2. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
Warheit DB; Donner EM
Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening.
Nel A; Xia T; Meng H; Wang X; Lin S; Ji Z; Zhang H
Acc Chem Res; 2013 Mar; 46(3):607-21. PubMed ID: 22676423
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis of nanomaterials hazard and risk.
Cohen Y; Rallo R; Liu R; Liu HH
Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
[TBL] [Abstract][Full Text] [Related]
6. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies.
Klein CL; Wiench K; Wiemann M; Ma-Hock L; van Ravenzwaay B; Landsiedel R
Arch Toxicol; 2012 Jul; 86(7):1137-51. PubMed ID: 22532024
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
[TBL] [Abstract][Full Text] [Related]
8. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
9. Development of a multilevel approach for the evaluation of nanomaterials' toxicity.
Galluzzi L; Chiarantini L; Pantucci E; Curci R; Merikhi J; Hummel H; Bachmann PK; Manuali E; Pezzotti G; Magnani M
Nanomedicine (Lond); 2012 Mar; 7(3):393-409. PubMed ID: 22047028
[TBL] [Abstract][Full Text] [Related]
10. [Safety of medicinal nanoproducts: new areas of toxicological research].
Grudziński IP
Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
[TBL] [Abstract][Full Text] [Related]
11. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity.
Fako VE; Furgeson DY
Adv Drug Deliv Rev; 2009 Jun; 61(6):478-86. PubMed ID: 19389433
[TBL] [Abstract][Full Text] [Related]
12. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
[TBL] [Abstract][Full Text] [Related]
13. Development of in vitro systems for nanotoxicology: methodological considerations.
Stone V; Johnston H; Schins RP
Crit Rev Toxicol; 2009; 39(7):613-26. PubMed ID: 19650720
[TBL] [Abstract][Full Text] [Related]
14. Toxicological aspects for nanomaterial in humans.
Dusinska M; Magdolenova Z; Fjellsbø LM
Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
[TBL] [Abstract][Full Text] [Related]
15. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
[TBL] [Abstract][Full Text] [Related]
16. Nanomaterial cell interactions: are current in vitro tests reliable?
Hirsch C; Roesslein M; Krug HF; Wick P
Nanomedicine (Lond); 2011 Jul; 6(5):837-47. PubMed ID: 21793675
[TBL] [Abstract][Full Text] [Related]
17. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
18. Toxicity testing in the 21st century: implications for human health risk assessment.
Krewski D; Andersen ME; Mantus E; Zeise L
Risk Anal; 2009 Apr; 29(4):474-9. PubMed ID: 19144067
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of information in nanomaterial safety data sheets and development of international standard for guidance on preparation of nanomaterial safety data sheets.
Lee JH; Kuk WK; Kwon M; Lee JH; Lee KS; Yu IJ
Nanotoxicology; 2013 May; 7(3):338-45. PubMed ID: 22263625
[TBL] [Abstract][Full Text] [Related]
20. A method to assess the quality of studies that examine the toxicity of engineered nanomaterials.
Card JW; Magnuson BA
Int J Toxicol; 2010 Jul; 29(4):402-10. PubMed ID: 20634541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
